Background-Prevalence of short segment Barrett's (SSB) oesophagus, defined as the absence of macroscopic Barrett's but histologically identifiable intestinal metaplasia, has been reported to be 18% based on haematoxylin and eosin (H&E) staining. Aims-To define the prevalence of SSB oesophagus using H&E and alcian blue staining and to determine whether SSB oesophagus is associated with inflammation at the gastro-oesophageal junction (GOJ). Subjects-Consecutive patients (n=158) presenting for endoscopy completed a structured interview. Methods-Two biopsy specimens taken from the GOJ were stained with H&E, alcian blue and Giemsa. A third specimen was obtained from the distal oesophagus. Intestinal metaplasia was diagnosed if goblet cells were definitely identified by two independent observers. Results-SSB oesophagus was present in 46 (prevalence 36%, 95% confidence interval (CI) 28.5-43.5) using alcian blue staining. IfH&E had been the sole staining method used, 50% cases of intestinal metaplasia would have been overlooked. There were no cases of intestinal metaplasia identified by H&E but missed by alcian blue stainling. Logistic regression analysis identified age (odds ratio (OR) per decade 103, 95% CI 1-01-1-06), histological oesophagitis (OR 3*2, 95% CI 1.4-7.2) and inflammation at the gastrooesophageal junction (OR 5*9, 95% CI 2-2-15-6) as independent risk factors for SSB oesophagus. Conclusion-Unrecognised SSB oesophagus is highly prevalent in patients presenting for diagnostic upper endoscopy if alcian blue staining is applied. (Gut 1997; 40: 710-715) 
Traditionally, Barrett's oesophagus is defined as the replacement of the distal oesophageal lining by three or more centimetres of circumferential columnar epithelium in continuity with the gastric mucosa.' However, the length of three centimetres, as required by the above definition, is purely arbitrary. The standard definition excludes tongues of columnar epithelium that are often seen at the gastrooesophageal junction.' Some investigators have recommended that the definition should be more appropriately based on the histological type rather than length.2 Cardia or junctional type epithelium in the distal oesophagus is not diagnostic of Barrett's oesophagus,3 but detection of specialised intestinal epithelium (as indicated by the presence of goblet cells) is abnormal. In patients who fail to fulfil the traditional definition, the presence of specialised intestinal epithelium has been referred to as short segment Barrett's oesophagus. ' 3 Barrett's oesophagus is a strong risk factor for adenocarcinoma of the oesophagus. 9 The neoplastic risk seems to be related to the presence of specialised intestinal type epithelium, and not the junctional or cardia types.'0 "1 There is increasing evidence that these adenocarcinomas can arise from very short segments of metaplastic epithelium. 6 12 Short segments of Barrett's oesophagus may often be overlooked during routine endoscopy because the gastro-oesophageal junction appears to be normal and biopsy specimens are not obtained. In a recent study, the prevalence of short segment Barrett's oesophagus was reported to be 18%. 13 Another preliminary report found a prevalence of 24%./14 However, the true prevalence in the community is still unclear as these studies used haematoxylin and eosin (H&E) staining alone to detect the specialised intestinal type epithelium. Alcian blue has been shown to be superior to H&E in detection of intestinal metaplasia,4 '5 but this method of diagnosis has not been evaluated in patients without standard Barrett's oesophagus. We hypothesised that the prevalence of short segment Barrett's oesophagus has been underestimated because of the methods used.
Barrett's oesophagus has been causally linked to chronic gastro-oesophageal reflux disease in humans'6-18 and in experimental models of Barrett's oesophagus, '9-22 
Methods

SUBJECTS
Consecutive outpatients booked for routine gastroscopy at Nepean Hospital (irrespective of their indication) were invited to participate in this study. The study was approved by the Wentworth Area Health Service Research and Ethics Committee. Patients were excluded from the study if they had known Barrett's oesophagus, were unwilling to participate or had conditions that did not permit a safe biopsy (for example, coagulopathy, oesophageal varices).
SYMPTOMS
All patients completed a structured interview that measured symptoms of gastro-oesophageal reflux disease (that is, heartburn, acid regurgitation and dysphagia). All subjects were interviewed individually by one of us (SN) and all the terms were specified to minimise measurement bias. The frequency of symptoms was graded as follows: 1, less than once a month; 2, once a month; 3, once a week; 4, several times a week; or 5, daily. The severity was graded as follows: 1, mild -can be ignored if I don't think about it; 2, moderate -cannot be ignored but does not affect my lifestyle; 3, severe -affects my lifestyle; or 4, very severe -noticeably affects my lifestyle.
The frequency and severity scores were added to compute combined scores for each symptom (ranges: heartburn score 0-9; acid regurgitation score 0-9; and dysphagia score 0-9). Relevant current medication history (use of antacids, H2-receptor antagonists or proton pump inhibitors) was 
HISTOLOGY
In the absence of clinically apparent Barrett's oesophagus, two biopsy specimens of the gastro-oesophageal junction were taken in each patient. The gastro-oesophageal junction was identified by noting the change in colour between the squamous and columnar epithelium. The biopsy sample was carefully taken from a piece of the columnar epithelium immediately distal to the z-line. These samples were fixed with 10% buffered formalin and then embedded in paraffin wax. Serial sections were cut at three levels from each specimen. Sections were stained with haematoxylin and eosin (H&E), alcian blue and Giemsa.
All sections were analysed independently for the presence of intestinal metaplasia, Helicobacter pylori and inflammation. The pathologists were unaware of the endoscopy and clinical data. On H&E staining, intestinal metaplasia was considered to be present if goblet cells were identified based on their goblet cup like shape and characteristic staining (basal nucleus and clear spherical apical cytoplasm). '3 Goblet cells contain acid mucin and stain intensely blue with alcian blue at pH 2.5.24 25 Columnar cells which stain less intensely with alcian blue are not diagnostic of Barrett's oesophagus as they can also be found in the mucus neck region of gastric glands. Positive identification of goblet cells with alcian blue in this study required the characteristic goblet shape and intense blue staining.4 Absence of either of the two characteristics negated the diagnosis of intestinal metaplasia in order to avoid overdiagnosis. A section of the small intestine was also stained simultaneously as a control.
H pylo?i was identified by using the Giemsa stain using the criteria of its characteristic morphology (small curved basophilus bacillus), position and distribution (closely applied to epithelial cell surface, present within the pits and in overlying mucus). 26 Inflammation at the gastro-oesophageal junction was diagnosed if increased numbers of lymphocytes and polymorphonuclear leucocytes were present in the lamina propria beneath the columnar epithelium.27 The Sydney System was used for the diagnosis of acute and chronic gastritis.28 Patients in whom both of the gastro-oesophageal junction biopsy specimens showed only stratified squamous epithelium but failed to include any columnar epithelium, were labelled as sampling error and were not included in the final analyses.
If endoscopically obvious Barrett's oesophagus was present (circumferential columnar lined oesophagus >3 cm in length), patients did not undergo biopsy according to the protocol. Instead, biopsy specimens were taken as a part of a Barrett's oesophagus screening programme. These patients were not included in further analyses.
An additional biopsy specimen was also taken from the oesophagus, 2 cm above the gastro-oesophageal junction. This was processed in identical manner (see earlier), but stained with H&E only and graded independently. Oesophagitis was identified if there was (1) basal cell hyperplasia >15% of the total epithelium, (2) Figure 1 shows intestinal metaplasia as detected by staining with alcian blue. On H&E staining alone (Fig 2) , intestinal metaplasia was detected in only 23 (15%) patients. There were no cases of intestinal metaplasia that were detected by H&E but missed by alcian blue staining. The prevalence of intestinal metaplasia detected by alcian blue and H&E staining is shown in Table I . This discrepancy is explained by our use of alcian blue which seemed to be superior to staining with H&E. In our study, the prevalence of intestinal metaplasia using H&E alone was 15%, which is comparable with the prevalence described by Spechler et al. '3 We found no cases of intestinal metaplasia that were detected by H&E but missed by alcian blue. We do not believe that the additional cases detected by alcian blue were likely to be false positives because we adhered to strict criteria for diagnosis.
ASSOCIATIONS
Our results are consistent with the application of alcian blue staining in other settings. Cooper et al obtained biopsy samples from 11 children (mean age 5 9 years) with standard Barrett's oesophagus.3' They identified five additional cases of specialised intestinal epithelium on staining with alcian blue that were missed with H&E staining. Gottfried et al, too, found alcian blue to be more sensitive than H&E in the diagnosis of intestinal metaplasia. 4 When strict criteria were used (that is, rejection of patients showing only diffuse acid mucin in the columnar cells with alcian blue), they concluded that goblet cell metaplasia detected by alcian blue is highly specific for the histological diagnosis of columnar lined (Barrett's) oesophagus. Because we used strict criteria in our study for the positive identification of goblet cells, we may have actually underestimated the prevalence of short segment Barrett's oesophagus, but we believe that any such error would be small. We recommend that alcian blue be used as a routine stain in the diagnosis of short segment Barrett's oesophagus.
We found that the prevalence of short segment Barrett's oesophagus was higher in older subjects. Epidemiological studies by Cameron et al32 and GOSPE33 have shown that standard Barrett's oesophagus is also age dependent. This supports the view that both these conditions are acquired. We adjusted for age in our analyses as this may have otherwise confounded our results.
A causal relation between gastro-oesophageal reflux disease and standard Barrett's oesophagus is believed to exist in humans,'1-8 and refluxate has been used to induce Barrett's mucosa in experimental models.'9-22 Nakano et al subjected Wistar rats to gastrectomy and an end to side anastomosis between the oesophagus and jejunum, resulting in free jejuno-oesophageal reflux. 22 They showed the appearance of columnar epithelium in the oesophagus replete with absorptive and goblet cells. These goblet cells were positively identified on staining with high iron diamine/alcian blue and concanavalin A type III. Martin et al performed gastroenterostomy and cardioplasty in dogs to promote free pancreaticoduodenal reflux into the oesophagus.2' Gastric acid secretion was inhibited with an oral proton pump inhibitor (omeprazole -40 ,umol/kg/day). The oesophageal mucosa was resected and allowed to heal in this modified environment. They noted healing with squamous epithelium at the proximal border whereas distal healing occurred with a columnar epithelium (with goblet cells). Barrett's epithelium has also been reported as a consequence of acid reflux after oesophageal myotomy in patients with achalasia. 34 It has been hypothesised that destruction of the stratified squamous epithelium and the subsequent repair process leads to the development of islands of intestinal metaplasia in the oesophagus. We We did not find any difference in the prevalence of H pylori at the gastro-oesophageal junction in the patients with and without short segment Barrett's oesophagus. We had postulated that a higher local prevalence of H pylori in patients with short segment Barrett's may account for increased inflammatory changes at the gastro-oesophageal junction. As the antrum and the corpus were not sampled, it is likely that we have underestimated the prevalence of H pylori distally. However, increased detection ofHpylori from the antrum would not necessarily negate reflux as a causal possibility as H pylori can coexist in patients with gastro-oesophageal reflux disease without being linked causally to the latter. We suspect that gastro-oesophageal reflux disease rather than H pyloni is the underlying pathophysiological mechanism causing inflammation at the gastro-oesophageal junction in patients with intestinal metaplasia.
Although there was an age related increase in prevalence in standard Barrett's oesophagus in one large study, no significant increase in length was noticed.32 This report suggested that standard Barrett's oesophagus develops to its full length all at once, usually many years before it is diagnosed, with no significant further increment in its length with time. Whether short segment Barrett's oesophagus is a completely separate entity or a precursor lesion for typical Barrett's oesophagus is unknown, but the former seems more likely based on the data available. A significant increase in the incidence of oesophageal adenocarcinoma has been noted in the past few decades,38 39 and these tumours are almost always associated with underlying specialised intestinal type epithelium rather than junctional or fundic type.'0 11 Anecdotal evidence based on case reports supports the view that adenocarcinoma is associated with short segment Barrett's oesophagus. 6 12 The very high prevalence of short segment Barrett's oesophagus may therefore be of clinical importance. There are no studies which have determined the cumulative risk of development of adenocarcinoma in patients with short segment Barrett's oesophagus. Moreover, the natural history of short segment Barrett's oesophagus has not been characterised carefully. Further studies are required before it will be known whether guidelines for surveillance in patients with short segment Barrett's oesophagus will need to be developed.
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